LIGAND PHARMACEUTICALS INCORPORATED
Net Cash Flow Breakdown
Total Cash from Operations: $633.3M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $260.8K | 0.0% |
| Other Investing | $217.5M | 34.3% |
| Working Capital | $155.7M | 24.6% |
| Other | $157.2M | 24.8% |
| Net Cash Flow | $102.6M | 16.2% |